Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer

David S Alberts, M. Markman, F. Muggia, R. F. Ozols, E. Eldermire, M. A. Bookman, T. Chen, J. Curtin, L. M. Hess, L. Liebes, R. C. Young, E. Trimble

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Ovarian cancer is the leading cause of gynecologic cancer deaths in the U.S. The concept of intraperitoneal drug delivery for therapy of intraperitoneal cancers, such as ovarian cancer, arose in the 1960s. The field of intraperitoneal cisplatin therapy for ovarian cancer was initiated in the late 1970s and early 1980s. The markedly improved survival data resulting from a phase III trial of intraperitoneal cisplatin for ovarian cancer in early 2006 led to an NCI Clinical Announcement and a Gynecologic Oncology Group-sponsored workshop on intraperitoneal therapy in January, 2006, in San Diego, California. The proceedings of this workshop summarize both research trial results and practical implementation issues associated with intraperitoneal therapy discussed at this workshop.

Original languageEnglish (US)
Pages (from-to)783-792
Number of pages10
JournalGynecologic Oncology
Volume103
Issue number3
DOIs
StatePublished - Dec 2006

Fingerprint

Ovarian Neoplasms
Education
Cisplatin
Therapeutics
Neoplasms
Drug Therapy
Research

Keywords

  • Intraperitoneal chemotherapy
  • Oncology
  • Ovarian cancer

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Alberts, D. S., Markman, M., Muggia, F., Ozols, R. F., Eldermire, E., Bookman, M. A., ... Trimble, E. (2006). Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer. Gynecologic Oncology, 103(3), 783-792. https://doi.org/10.1016/j.ygyno.2006.09.012

Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer. / Alberts, David S; Markman, M.; Muggia, F.; Ozols, R. F.; Eldermire, E.; Bookman, M. A.; Chen, T.; Curtin, J.; Hess, L. M.; Liebes, L.; Young, R. C.; Trimble, E.

In: Gynecologic Oncology, Vol. 103, No. 3, 12.2006, p. 783-792.

Research output: Contribution to journalArticle

Alberts, DS, Markman, M, Muggia, F, Ozols, RF, Eldermire, E, Bookman, MA, Chen, T, Curtin, J, Hess, LM, Liebes, L, Young, RC & Trimble, E 2006, 'Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer', Gynecologic Oncology, vol. 103, no. 3, pp. 783-792. https://doi.org/10.1016/j.ygyno.2006.09.012
Alberts, David S ; Markman, M. ; Muggia, F. ; Ozols, R. F. ; Eldermire, E. ; Bookman, M. A. ; Chen, T. ; Curtin, J. ; Hess, L. M. ; Liebes, L. ; Young, R. C. ; Trimble, E. / Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer. In: Gynecologic Oncology. 2006 ; Vol. 103, No. 3. pp. 783-792.
@article{cc444f4d7aef42ccbacf30e290d6607f,
title = "Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer",
abstract = "Ovarian cancer is the leading cause of gynecologic cancer deaths in the U.S. The concept of intraperitoneal drug delivery for therapy of intraperitoneal cancers, such as ovarian cancer, arose in the 1960s. The field of intraperitoneal cisplatin therapy for ovarian cancer was initiated in the late 1970s and early 1980s. The markedly improved survival data resulting from a phase III trial of intraperitoneal cisplatin for ovarian cancer in early 2006 led to an NCI Clinical Announcement and a Gynecologic Oncology Group-sponsored workshop on intraperitoneal therapy in January, 2006, in San Diego, California. The proceedings of this workshop summarize both research trial results and practical implementation issues associated with intraperitoneal therapy discussed at this workshop.",
keywords = "Intraperitoneal chemotherapy, Oncology, Ovarian cancer",
author = "Alberts, {David S} and M. Markman and F. Muggia and Ozols, {R. F.} and E. Eldermire and Bookman, {M. A.} and T. Chen and J. Curtin and Hess, {L. M.} and L. Liebes and Young, {R. C.} and E. Trimble",
year = "2006",
month = "12",
doi = "10.1016/j.ygyno.2006.09.012",
language = "English (US)",
volume = "103",
pages = "783--792",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer

AU - Alberts, David S

AU - Markman, M.

AU - Muggia, F.

AU - Ozols, R. F.

AU - Eldermire, E.

AU - Bookman, M. A.

AU - Chen, T.

AU - Curtin, J.

AU - Hess, L. M.

AU - Liebes, L.

AU - Young, R. C.

AU - Trimble, E.

PY - 2006/12

Y1 - 2006/12

N2 - Ovarian cancer is the leading cause of gynecologic cancer deaths in the U.S. The concept of intraperitoneal drug delivery for therapy of intraperitoneal cancers, such as ovarian cancer, arose in the 1960s. The field of intraperitoneal cisplatin therapy for ovarian cancer was initiated in the late 1970s and early 1980s. The markedly improved survival data resulting from a phase III trial of intraperitoneal cisplatin for ovarian cancer in early 2006 led to an NCI Clinical Announcement and a Gynecologic Oncology Group-sponsored workshop on intraperitoneal therapy in January, 2006, in San Diego, California. The proceedings of this workshop summarize both research trial results and practical implementation issues associated with intraperitoneal therapy discussed at this workshop.

AB - Ovarian cancer is the leading cause of gynecologic cancer deaths in the U.S. The concept of intraperitoneal drug delivery for therapy of intraperitoneal cancers, such as ovarian cancer, arose in the 1960s. The field of intraperitoneal cisplatin therapy for ovarian cancer was initiated in the late 1970s and early 1980s. The markedly improved survival data resulting from a phase III trial of intraperitoneal cisplatin for ovarian cancer in early 2006 led to an NCI Clinical Announcement and a Gynecologic Oncology Group-sponsored workshop on intraperitoneal therapy in January, 2006, in San Diego, California. The proceedings of this workshop summarize both research trial results and practical implementation issues associated with intraperitoneal therapy discussed at this workshop.

KW - Intraperitoneal chemotherapy

KW - Oncology

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=33751427410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751427410&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2006.09.012

DO - 10.1016/j.ygyno.2006.09.012

M3 - Article

C2 - 17070570

AN - SCOPUS:33751427410

VL - 103

SP - 783

EP - 792

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -